Table of Contents Author Guidelines Submit a Manuscript
Research Article
Anesthesiology Research and Practice
Volume 2017, Article ID 1368514, 1 page

Corrigendum to “Sugammadex-Enhanced Neuronal Apoptosis following Neonatal Sevoflurane Exposure in Mice”

1Department of Anesthesiology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 1138519, Japan
2Department of Anesthesiology, Graduate School of Medicine, Nagoya University, Aichi, Japan

Correspondence should be addressed to Maiko Satomoto;

Received 26 July 2017; Accepted 9 August 2017; Published 17 October 2017

Copyright © 2017 Maiko Satomoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Sugammadex-Enhanced Neuronal Apoptosis following Neonatal Sevoflurane Exposure in Mice” [1], the concentration of sugammadex injected into the mice, 30 mg/kg, was incorrect; the correct concentration is 300 mg/kg. The undiluted sugammadex concentration was 100 mg/ml and not 10 mg/ml. Accordingly, in the section “Sugammadex Treatment,” the statement “with a single 30 mg/kg dose” should be corrected to “with a single 300 mg/kg dose” and, in the Discussion section, the statement “we chose 30 mg/kg” should be corrected to “In this study, we chose 300 mg/kg.”


  1. M. Satomoto, Z. Sun, Y. U. Adachi, and K. Makita, “Sugammadex-enhanced neuronal apoptosis following neonatal sevoflurane exposure in mice,” Anesthesiology Research and Practice, vol. 2016, Article ID 9682703, pp. 1–6, 2016. View at Publisher · View at Google Scholar · View at Scopus